School of Medicine, Shenzhen University, Shenzhen, China.
Department of General Medicine, Shenzhen University General Hospital, Shenzhen, China.
Respir Care. 2021 Mar;66(3):501-509. doi: 10.4187/respcare.07489. Epub 2020 Nov 3.
Music therapy, as a non-drug therapy, is widely used in patients with COPD. However, the effects of music therapy on dyspnea, anxiety, depression and other physiological parameters has not been elucidated. Therefore, we sought to investigate the effects of passive music therapy (listening to music) and mixed music (combination of listening and singing) in adults with COPD.
A systematic literature search was performed in PubMed, Cochrane, Embase, Web of Science, China National Knowledge Infrastructure, VIP, and Wanfang Data up to June 26, 2019. All randomized controlled trials that compared music with usual care or other non-musical types of intervention in subjects with COPD were included in the study. The risk of bias for randomized controlled trials was assessed with the Cochrane risk of bias tool. Outcomes included dyspnea, anxiety, depression, sleep quality, and quality of life, as well as physiological parameters (eg, blood pressure and breathing frequency).
After initial screening of 216 potentially relevant records, 59 studies were eligible, and 12 studies with 812 participates met the inclusion criteria and were included in the final meta-analysis. Analysis showed that music therapy had a significant effect in relieving dyspnea (mean difference: -0.69, 95% CI -0.80 to -0.58, < .001) and anxiety (standardized mean difference: -1.87, 95% CI -2.72 to -1.02, < .001) in adults with COPD. Compared with the control group, music had no statistically significant effect on depression or St George Respiratory Questionnaire score. However, when it came to improving sleep quality, music reduced the total Pittsburgh Sleep Quality Index score ( < .001). In addition, the pooled results showed that there was a significant improvement in systolic blood pressure (mean difference: -7.45, 95% CI -10.95 to -3.96, < .001) and diastolic blood pressure (mean difference: -4.07, 95% CI -7.03 to -1.12, = .007) in the music group compared to the control.
Music therapy is effective in reducing dyspnea and anxiety in subjects with COPD. Additionally, music therapy may also improve sleep quality and physiological parameters of subjects with COPD. However, our conclusions need to be supported further by larger and longer well-designed trials.
音乐疗法作为一种非药物疗法,在 COPD 患者中得到了广泛应用。然而,音乐疗法对呼吸困难、焦虑、抑郁等生理参数的影响尚未阐明。因此,我们旨在研究被动音乐疗法(听音乐)和混合音乐(听与唱结合)对 COPD 成人的影响。
系统检索了 PubMed、Cochrane、Embase、Web of Science、中国知网、维普和万方数据库,检索时间截至 2019 年 6 月 26 日,纳入比较音乐疗法与常规护理或其他非音乐干预措施在 COPD 患者中应用的随机对照试验。使用 Cochrane 偏倚风险工具评估随机对照试验的偏倚风险。结局指标包括呼吸困难、焦虑、抑郁、睡眠质量和生活质量以及生理参数(如血压和呼吸频率)。
经过对 216 篇潜在相关记录的初步筛选,共有 59 项研究符合纳入标准,其中 12 项研究共 812 名参与者纳入最终的荟萃分析。结果显示,音乐疗法可显著减轻 COPD 患者的呼吸困难(均数差:-0.69,95%置信区间-0.80 至-0.58,<0.001)和焦虑(标准化均数差:-1.87,95%置信区间-2.72 至-1.02,<0.001)。与对照组相比,音乐对抑郁或圣乔治呼吸问卷评分无统计学意义。然而,在改善睡眠质量方面,音乐疗法可降低匹兹堡睡眠质量指数总分(<0.001)。此外,汇总结果显示,与对照组相比,音乐疗法可显著降低收缩压(均数差:-7.45,95%置信区间-10.95 至-3.96,<0.001)和舒张压(均数差:-4.07,95%置信区间-7.03 至-1.12,=0.007)。
音乐疗法可有效减轻 COPD 患者的呼吸困难和焦虑。此外,音乐疗法可能改善 COPD 患者的睡眠质量和生理参数。然而,我们的结论需要更大规模、更长时间、设计更好的试验进一步支持。